Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

crawled date : 2021 - 12 - 20    source : Www.biospace.com    save search

Bio-Rad Introduces Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays to Quickly Measure Neutralizing Antibodies Against SARS-CoV-2 Virus
Published: 2021-12-20 (Crawled : 21:00) - biospace.com/
BIO | $280.13 0.14% 0.0% 1 twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 0.74% C: -0.46%

sars-cov-2 antibody
Waters Corporation Presentation at the 40th Annual J.P. Morgan Healthcare Conference to be Webcast Live
Published: 2021-12-20 (Crawled : 21:00) - biospace.com/
WAT | $299.23 1.06% 0.0% 290K twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.48% C: -0.16%

health thc conference presentation j.p. morgan healthcare conference
Clinical Catch-Up: December 11-17
Published: 2021-12-20 (Crawled : 20:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.59% 440K twitter stocktwits trandingview |
Health Technology
| | O: -1.24% H: 0.42% C: -0.04%


Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression in Adults
Published: 2021-12-20 (Crawled : 18:00) - biospace.com/
ITCI 4 d | $74.54 3.0% 2.96% 58 twitter stocktwits trandingview |
Health Technology
| | O: 12.0% H: 11.72% C: 3.4%

caplyta treatment fda fda approval approval cel depression therapy
Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply
Published: 2021-12-20 (Crawled : 17:00) - biospace.com/
PFE | News A | $26.26 1.0% 0.38% 29M twitter stocktwits trandingview |
Health Technology
| | O: 1.88% H: 1.83% C: 0.69%
SNY | News | $47.15 1.84% 1.75% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.59% H: 0.18% C: -0.2%
BNTX | News | $88.01 1.38% 1.36% 240 twitter stocktwits trandingview |
Health Technology
| | O: 6.79% H: 0.98% C: -8.08%

comirnaty comirnaty® europe vaccine
Arcadia Biosciences (RKDA) Appoints Kevin Comcowich to Interim CEO
Published: 2021-12-20 (Crawled : 17:00) - biospace.com/
RKDA | $2.12 2.91% 1.9% 66K twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 0.0% C: -1.43%

ceo bioscience
Aileron Therapeutics Issues Statement on Passing of Scientific Advisory Board Member and Nobel Laureate Robert H. Grubbs
Published: 2021-12-20 (Crawled : 17:00) - biospace.com/
ALRN | $4.75 0.21% 1.25% 110K twitter stocktwits trandingview |
Health Technology
| | O: -2.02% H: 3.95% C: -1.74%

urea therapeutics
ALR Technologies Releases an Open Letter to Shareholders
Published: 2021-12-20 (Crawled : 17:00) - biospace.com/
ALRT | $0.0297 twitter stocktwits trandingview |
Manufacturing
| | O: 7.84% H: 0.0% C: 0.0%

air technology
ObsEva Added to the NASDAQ Biotechnology Index
Published: 2021-12-20 (Crawled : 17:00) - biospace.com/
OBSV | $0.1018 -15.52% -18.95% 8.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.88% H: 0.89% C: -4.0%

technology nasdaq index biotech iot
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholde
Published: 2021-12-20 (Crawled : 15:30) - biospace.com/
ANVS | $11.49 14.22% -3.05% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 5.84% C: 2.75%

ceo
Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection
Published: 2021-12-20 (Crawled : 15:30) - biospace.com/
CARA | $0.7304 10.5% 9.37% 100 twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.2% C: -1.34%

therapeutics injection granted grant
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Phase 2 Multi-Indication Trial Using Vidutolimod
Published: 2021-12-20 (Crawled : 15:30) - biospace.com/
CMPI | $10.5 0.0% twitter stocktwits trandingview |
Health Technology
| | O: 2.11% H: 25.43% C: 8.25%

phase 2 als trial
Sorrento Therapeutics Announces FDA Clearance of Its IND Application of Next Generation oHSV Oncolytic Virus STI-1386 for Patients With Relapsed and Refractory Solid Tumors
Published: 2021-12-20 (Crawled : 15:30) - biospace.com/
SRNE | $0.015 -25.0% -8.85% 140K twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 1.49% C: -2.34%

sti-1386 fda clearance solid tumors application therapeutics fda clearance
Turning Point Therapeutics Provides Regulatory Updates
Published: 2021-12-20 (Crawled : 15:30) - biospace.com/
TPTX | $76.01 -0.03% twitter stocktwits trandingview |
Health Technology
| | O: -7.33% H: 13.38% C: 10.88%

therapeutics
BIOATLA TO PRESENT AT 40th ANNUAL J.P. MORGAN VIRTUAL HEALTHCARE CONFERENCE
Published: 2021-12-20 (Crawled : 15:30) - biospace.com/
BCAB | $2.18 3.56% 3.0% 750 twitter stocktwits trandingview |
| | O: 2.18% H: 6.51% C: -2.73%

health thc conference
Reviva Pharmaceuticals to Participate in the Upcoming January Virtual Investor Conferences
Published: 2021-12-20 (Crawled : 15:00) - biospace.com/
RVPH | $3.09 2.32% 2.27% 110K twitter stocktwits trandingview |
| | O: 3.81% H: 5.33% C: -1.33%

als conference
Finch Therapeutics Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer
Published: 2021-12-20 (Crawled : 15:00) - biospace.com/
FNCH | $2.31 3.13% 6.28% 370 twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.45% H: 11.11% C: 8.64%

therapeutics
Coherus Announces U.S. FDA Approval of YUSIMRY™ (adalimumab-aqvh)
Published: 2021-12-20 (Crawled : 15:00) - biospace.com/
CHRS | $2.18 5.31% 5.48% 1.1K twitter stocktwits trandingview |
Health Technology
| | O: 1.85% H: 1.17% C: 0.64%

fda fda approval approval
Galecto Provides Enrollment Update on Phase 2a MYLOX-1 Trial and Reiterates Expected Timing of Multiple Data Readouts in 2022
Published: 2021-12-20 (Crawled : 15:00) - biospace.com/
GLTO | $0.681 -0.07% 0.32% 62K twitter stocktwits trandingview |
Health Technology
| | O: -4.61% H: 11.9% C: 6.51%

phase 2 trial readout enroll phase 2b
MediWound Announces Positive Initial Data from its U.S. Phase 2 Pharmacology Study of EscharEx Showing Effective and Rapid Debridement in Chronic and Hard to Heal Wounds
Published: 2021-12-20 (Crawled : 15:00) - biospace.com/
MDWD | $15.76 -0.06% 0.19% 29K twitter stocktwits trandingview |
Health Technology
| | O: -0.82% H: 1.24% C: -2.89%

phase 2 positive
Gainers vs Losers
73% 27%

Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M twitter stocktwits trandingview |
Finance

EDBL | News | $6.26 66.49% 48.56% 270K twitter stocktwits trandingview |

MLEC | $2.47 76.43% 38.05% 460K twitter stocktwits trandingview |
n/a

SILO | $1.99 0.71% 20.64% 1.8M twitter stocktwits trandingview |
Finance and Insurance

NNVC | $1.12 1.82% 19.64% 2.5K twitter stocktwits trandingview |
Health Technology

CANG | $1.34 -4.29% 14.93% 120K twitter stocktwits trandingview |
Technology Services

AZTR 4 | $0.195 13.85% 42K twitter stocktwits trandingview |
n/a

TOVX | News | $0.411 -1.01% 12.9% 230K twitter stocktwits trandingview |
Manufacturing

IBRX | $4.94 -6.26% 10.83% 4.5M twitter stocktwits trandingview |
Manufacturing

MSTR M | $1324.01 12.77% 10.65% 26K twitter stocktwits trandingview |
Technology Services


Your saved searches
Save your searches and get alerts when important news are released.